Landen Jaren 4
4 · CASSAVA SCIENCES INC · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Landen Jaren
Chief Clinical Dev. Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-11-18+85,000→ 85,000 totalExercise: $27.95Exp: 2034-11-18→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025.